Dr. Deepak L. Bhatt
@DLBHATTMD
Followers
40K
Following
47K
Media
204
Statuses
16K
Dr. Deepak L. Bhatt is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine. Bio and COI: https://t.co/ngtk4hxfDG.
New York City
Joined December 2009
After 14 wonderful years at @BrighamWomens, @MassGenBrigham, @DanaFarber, and @VABostonHC, I am happy to announce that I will be the Director of @MountSinaiHeart at @MountSinaiNYC and the Dr. Valentin Fuster Professor of CV Medicine at @IcahnMountSinai.
mountsinai.org
270
91
2K
🏆Congratulations to the authors of the Most Read Article in November! Read here: https://t.co/arzhVy8pZP
@DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
0
11
42
Oxidized phospholipids on apo B-100 is independently associated with MACE after ACS, an effect which is attenuated with PCSK9i therapy @VeraBittner2 @gabrielsteg @DLBhattMD @W66588221White @Christa @Lpa_doc
https://t.co/xThUrZQ8UK
1
6
19
Oxidized phospholipids on apo B-100 is independently associated with MACE after ACS, an effect which is attenuated with PCSK9i therapy @VeraBittner2 @gabrielsteg @DLBhattMD @W66588221White @Christa @Lpa_doc
https://t.co/xThUrZQ8UK
1
6
19
🏆Congratulations to the authors of the Most Read Article in November! Read here: https://t.co/arzhVy8pZP
@DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
0
11
42
Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights @AJPCardio @ASPCardio
@analyzeF @DrMichaelShapir @FaRodriguezMD @SethShayMartin @DrMarthaGulati @RonBlankstein @DLBHATTMD @NMHheartdoc
https://t.co/pxomOkrkIk
0
2
12
✨Video of the Week: Successful Re-endovascular Intervention of Distal Stent Graft-Induced New Entry With Endoleak After Thoracic Endovascular Aortic Repair ▶️ https://t.co/lH7WM1URYg
@klz13657254286 @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
0
2
16
Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights @AJPCardio @ASPCardio
@analyzeF @DrMichaelShapir @FaRodriguezMD @SethShayMartin @DrMarthaGulati @RonBlankstein @DLBHATTMD @NMHheartdoc
https://t.co/pxomOkrkIk
0
2
12
✨Video of the Week: Successful Re-endovascular Intervention of Distal Stent Graft-Induced New Entry With Endoleak After Thoracic Endovascular Aortic Repair ▶️ https://t.co/lH7WM1URYg
@klz13657254286 @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
0
2
16
🆕in Early View: Webs and Lakes in the Heart Read here: https://t.co/Oz9qpSaXYi
@DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
1
5
30
🆕in Early View: Webs and Lakes in the Heart Read here: https://t.co/Oz9qpSaXYi
@DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
1
5
30
Now out in @JACCJournals, our latest analysis from #CAMEO Registry shows that Cangrelor use is common (42%) in Acute MI patients getting CABG & linked to faster time-to-CABG & shorter hospital stay! Led by Drs. Rymer @DukeCardiology & @ronwaksman Read 🔗 https://t.co/HOXgYbWoZ6
0
6
22
Cardiac Remodeling in Preeclampsia: A Large-Language-Model-Assisted Meta-Analysis and Meta-Regression, by Teperidikis et al https://t.co/CAomB19DCP
@JCVPOnline @DLBHATTMD @GreggWStone @booz_w
0
4
11
Now out in @JACCJournals, our latest analysis from #CAMEO Registry shows that Cangrelor use is common (42%) in Acute MI patients getting CABG & linked to faster time-to-CABG & shorter hospital stay! Led by Drs. Rymer @DukeCardiology & @ronwaksman Read 🔗 https://t.co/HOXgYbWoZ6
0
6
22
Cardiac Remodeling in Preeclampsia: A Large-Language-Model-Assisted Meta-Analysis and Meta-Regression, by Teperidikis et al https://t.co/CAomB19DCP
@JCVPOnline @DLBHATTMD @GreggWStone @booz_w
0
4
11
Dr Bhatt speaking about clinical trial update in atherosclerosis at Toronto Heart @DLBHATTMD @BobbyYanagawa still over 4000 registration !
0
2
32
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? Aspirin has represented the mainstay of antiplatelet therapy for decades, emerging evidence suggests that P2Y₁₂ inhibitors may be more than just a viable alternative to aspirin and may be
0
7
24
#cardiology #cardiovascular #cardiotwitter #cardioX #diabetes #kidneydisease #heartfailure @JAMANetwork
🩸 SGLT2 inhibitors protect kidneys at all stages Meta-analysis of 70,000+ participants across 10 RCTs SGLT2 inhibitors ⬇️ CKD progression risk by 38% Effective regardless of eGFR or albuminuria, even in stage 4 CKD or minimal albuminuria. 💪 Consistent kidney protection
2
2
14
Dr Bhatt speaking about clinical trial update in atherosclerosis at Toronto Heart @DLBHATTMD @BobbyYanagawa still over 4000 registration !
0
2
32
Should P2Y12 inhibitor be preferred over aspirin for long treatment in ASCVD patients? https://t.co/cneG1rE1XI
@DFCapodanno @vlgmrc @DLBHATTMD @CMichaelGibson @FeliceGragnano @Drroxmehran
1
15
49
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? Aspirin has represented the mainstay of antiplatelet therapy for decades, emerging evidence suggests that P2Y₁₂ inhibitors may be more than just a viable alternative to aspirin and may be
0
7
24